|Phase contrast micrograph of S. iniae colonies stained with streptavidin-FITC|
Streptococcus shiloi (Eldar, 1994)
Streptococcus iniae is a species of Gram-positive, sphere-shaped bacterium belonging to the genus Streptococcus. Since its isolation from an Amazon freshwater dolphin in the 1970s, S. iniae has emerged as a leading fish pathogen in aquaculture operations worldwide, resulting in over US$100M in annual losses. Since its discovery, S. iniae infections have been reported in at least 27 species of cultured or wild fish from around the world. Freshwater and saltwater fish including tilapia, red drum, hybrid striped bass, and rainbow trout are among those susceptible to infection by S. iniae. Infections in fish manifest as meningoencephalitis, skin lesions, and septicemia.
S. iniae has occasionally produced infection in humans, especially fish handlers of Asian descent. Human infections include sepsis, toxic shock syndrome, and inflammation of the skin, intervertebral discs, or inner layer of the heart. Identifying S. iniae in the laboratory can be difficult, since the conventional methods used to identify streptococci yield insufficient results. It cannot be grouped by the Lancefield antigen method typically used to categorize Streptococci species. The two known serotypes can be distinguished biochemically by differences in enzyme activity. Several antibiotics have been used to treat S. iniae infections.
Streptococcus iniae was first isolated in 1972, from subcutaneous abscesses in a captive specimen of Amazon River Dolphin (Inia geoffrensis) suffering from an infection known as "golf ball disease". The bacterium was found to be sensitive to beta-lactam antibiotics, and the dolphin was treated successfully with penicillin and tylosin. The causative organism was recognized to be a new species of Streptococcus, and was given the name Streptococcus iniae in 1976. Around this time, other streptococcal outbreaks occurred in Asia, and the US; some of the strains associated with the Japanese outbreaks were later suggested to be S. iniae.
In the 1980s, a purported new species of Streptococcus, named S. shiloi, was identified as one of the causes of an epidemic of meningoencephalitis (an inflammation of the brain and its surrounding membranes) affecting farmed rainbow trout and tilapia in Israel since 1986. Since S. shiloi was alpha-hemolytic, had a G+C% content of 37% and did not ferment sugar galactose, it was not classified as S. iniae, which is beta-hemolytic, has a G+C% content of 32%, and ferments galactose. In 1995, S. shiloi was found in fact to be beta-hemolytic, and after DNA-DNA hybridization techniques with the ATCC type S. iniae and recalculation of the G+C% content, was reclassified by the same group as a junior synonym of S. iniae.
Phylogenetic analyses based on 16S ribosomal DNA suggest that S. iniae is closely related to other streptococcal pathogens of humans and animals. Specifically, it is clustered in the pyogenic group, along with other pathogenic streptococci such as S. pyogenes, S. agalactiae, S. uberis, S. canis, S. porcinus, S. phocae, and S. intestinalis. Of these related species, it is most closely related to S. porcinus. Genomic restriction fragment analysis of diverse host and geographical panels of S. iniae isolates has shown common profiles between virulent fish and human strains, though multiple pulsed field gel electrophoresis patterns have been identified among human isolates.
Streptococcus iniae may be easily misidentified (or not identified at all) by conventional automated microbiology systems. Molecular genetics methods, such as DNA sequencing and DNA-DNA hybridization, can be useful for correct identification, although work by the U.S. Centers for Disease Control and Prevention has suggested they are unnecessary in most cases. Several groups have used 16S rDNA sequencing to identify S. iniae isolates, and while it can differentiate this species from other related species, such as S. porcinus and S. uberis, 16S sequencing cannot be used to differentiate between strains of S. iniae. Ribotyping is a similar method, by which 16S and 23S rRNA genes are digested with restriction endonucleases and Southern blotted using species-specific oligonucleotide probes. This method is more sensitive than 16S rDNA sequencing, as in addition to species differentiation, it can be used to differentiate between strains. Ribotyping was used in 1997 to differentiate between Israeli and American strains, thus ruling out the possibility of an epidemiological link between outbreaks in the two countries.
Streptococcus iniae is beta-hemolytic when incubated in anaerobic conditions, although it may be misidentified as alpha-hemolytic because, in some strains, zones of beta-hemolysis (complete destruction of red blood cells in the blood agar culture media) are surrounded by large zones of alpha-hemolysis (incomplete destruction of red blood cells with a greenish discoloration due to breakdown of hemoglobin). The bacterium is catalase-negative and LAP-positive (like all streptococci), PYR-test and CAMP-test-positive, does not hydrolyze sodium hippurate and does not grow in bile esculin agar. It does not express any of the known Lancefield antigens.
There are two established serotypes of S. iniae. The ATCC 29178 type strain first characterized in 1976 by Pier and Madin is representative of Serotype I isolates. Serotype II was first identified as the type strain (ATCC 29177) isolated from another dolphin case of "golf ball disease". A biochemical assay measuring arginine dihydrolase activity has been used to distinguish between serotypes (Serotype I is positive), though proposed hyper-encapsulation of Serotype II may represent the most significant functional difference between the two types.
Role in disease
Streptococcus iniae is highly pathogenic in freshwater, marine, and euryhaline fish, and is highly lethal: outbreaks may be associated with 30–50% mortality. It is therefore one of the foremost economically important pathogens in intensive aquaculture. In 1997, the global economic impact of S. iniae infection to the aquaculture industry was estimated at US$100 million (one-tenth of which in the United States). As of 2007, infection had been reported in twenty-seven species of fish, including tilapia (genus Oreochromis and Tilapia), rainbow trout (Oncorhynchus mykiss), coho salmon (Oncorhynchus kisutch), Japanese amberjack (Seriola quinqueradiata), red drum (Sciaenops ocellatus), and barramundi (Lates calcarifer, which can be an asymptomatic carrier). Common carp (Cyprinus carpio), channel catfish (Ictalurus punctatus), and goldfish (Carassius auratus) appear to be resistant. Fish raised in intensive aquaculture operations and subject to environmental stressors (i.e. suboptimal temperature, poor water quality, crowding, handling, etc.) are most prone to S. iniae infection. Wild fish populations located both near and far from aquaculture operations have also proven susceptible to S. iniae infection.
The site of S. iniae infection and its clinical presentation vary from species to species. In tilapia, S. iniae causes meningoencephalitis, with symptoms including lethargy, dorsal rigidity, and erratic swimming behavior; death follows in a matter of days. In rainbow trout, it is typically associated with septicemia and central nervous system damage. Symptoms are consistent with septicemia, and include lethargy and loss of orientation (as in tilapia), exophthalmia, corneal opacity, and external and internal bleeding.
Streptococcus iniae can cause opportunistic infections in weakened or immunocompromised humans. It is most commonly associated with bacteremic cellulitis, but has been known to cause endocarditis, meningitis, osteomyelitis, and septic arthritis. The first recognized cases of human infection occurred in Texas in 1991 and in Ottawa in 1994, but the sources of infection were not determined. Human infection with S. iniae was also identified in Toronto between 15 and 20 December 1995, when three Asian patients were admitted to a hospital with cellulitis of the hand after injuring themselves while handling raw fish. All three were found to have bacteremia, initially attributed to Streptococcus uberis, but later correctly identified as S. iniae. In February 1996, a Chinese man was admitted to the same hospital with sepsis one week after preparing a fresh whole tilapia, and was also diagnosed with S. iniae bacteremia. A subsequent epidemiological investigation found other cases in the Toronto area, for a total of nine patients; all were of Asian descent and all had handled raw fish (mostly tilapia) before developing infection. Other cases were later identified in the United States and elsewhere in Canada, and have since been reported in Asia (Hong Kong, Taiwan, and Singapore). Asian descent is a common trend in the majority of invasive human cases, but it is unknown whether this is due to inherent differences in immunity or because of cultural differences in the fish preparation which lend themselves to a higher incidence of infection.
Control and treatment
Several measures can be taken to control infection in aquaculture once a S. iniae outbreak has been confirmed. Decreasing the quantity of feed given to fish has been shown to reduce mortality rates, as the uptake of bacteria in water is expedited by feeding. Decreasing the density of the fish stock increases survival by reducing injury to fish and lowering the general stress level in the population. Lowering the water temperature and keeping optimal oxygen levels has also been shown to reduce stress to fish and inhibit bacterial growth.
A 2005 study showed the potential for using probiotics for controlling S. iniae infection in trout. This study used the gastrointestinal contents of rainbow trout to scan for bacteria that inhibited growth of S. iniae and Lactococcus garvieae. They identified Aeromonas sobria as a potential candidate for control of S. iniae and L. garvieae infections in aquaculture. A. sobria, given live in the feed, protected the trout when challenged with S. iniae or L. garvieae.
Several antibiotics have been used successfully to treat S. iniae infection in fish. Enrofloxacin, a quinolone antibiotic, has been used to great effect in hybrid striped bass (Morone chrysops × M. saxatilis), although evidence suggested the development of a resistant strain. Amoxicillin, erythromycin, furazolidone, and oxytetracycline have also been used (the last with varying success, only in barramundi). Vaccination against S. iniae has been attempted with limited success as it only provides up to 6 months' immunity.
Penicillin has been suggested as the drug of choice for the treatment of S. iniae infection in mammals, including humans. In the 1995–1996 cluster of human cases, all clinical isolates were susceptible to penicillin, several cephalosporins, clindamycin, erythromycin, and co-trimoxazole (MICs 0.25 µg/mL); all nine patients were treated with parenteral beta-lactam antibiotics and recovered uneventfully. A study of isolates submitted to the Centers for Disease Control and Prevention between 2000 and 2004 found all to be sensitive to beta-lactams, macrolides, quinolones, and vancomycin.
- Pier GB, Madin SH. (1976). "Streptococcus iniae sp. nov., a beta-hemolytic streptococcus isolated from an Amazon Freshwater Dolphin, Inia geoffrensis". International Journal of Systematic Bacteriology 26 (4): 545–53. doi:10.1099/00207713-26-4-545.
- Kitao T, Aoki T, Sakoh R. (1981). "Epizootic caused by beta-hemolytic Streptococcus species in cultured freshwater fish". Fish Pathology 15: 301–7.
- Minami T, Nakamura M, Ikeda Y, Ozaki H. (1979). "A beta-hemolytic Streptococcus isolated from cultured yellowtail". Fish Pathology 14: 33–38.
- Plumb JA, Schachte JH, Gains JL, Peliter W, Carroll B. (1974). "Streptococcus sp. from marine fishes along the Alabama and northwest Florida coast of the Gulf of Mexico". Transactions of the American Fisheries Society 103 (2): 358–61. doi:10.1577/1548-8659(1974)103<358:SSFMFA>2.0.CO;2.
- Nakatsugawa T. (1983). "A streptococcal disease of cultured flounder". Fish Pathology 17: 281–85.
- Kitao T. (1993). "Streptococcal infections". In V. Inglis, R. J. Roberts, and N. R. Bromage. Bacterial Diseases of Fish. Oxford: Wiley-Blackwell. pp. 196–210. ISBN 978-0-632-03497-0.
- Eldar A, Bejerano Y, Bercovier H. (1994). "Streptococcus shiloi and Streptococcus difficile: two new streptococcal species causing a meningoencephalitis in fish". Current Microbiology 28 (3): 139–43. doi:10.1007/BF01571054.
- Eldar A, Frelier PF, Assenta L, et al. (1995). "Streptococcus shiloi, the name for an agent causing septicemic infection in fish, is a junior synonym of Streptococcus iniae". International Journal of Systematic Bacteriology 45 (4): 840–42. doi:10.1099/00207713-45-4-840.
- Facklam R, Elliott J, Shewmaker L, Reingold A. (2005). "Identification and characterization of sporadic isolates of Streptococcus iniae isolated from humans". Journal of Clinical Microbiology 43 (2): 933–37. doi:10.1128/JCM.43.2.933-937.2005. PMC 548108. PMID 15695711.
- Zlotkin A, Hershko H, Eldar A. (1998). "Possible transmission of Streptococcus iniae from wild fish to cultured marine fish". Applied and Environmental Microbiology 64 (10): 4065–67. PMC 106603. PMID 9758844.
- Kawamura Y, Hou XG, Sultana F, Miura H, Ezaki T. (1995). "Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus". International Journal of Systematic Bacteriology 45 (2): 406–8. doi:10.1099/00207713-45-2-406. PMID 7537076. Retrieved 2010-03-16.
- Poyart C, Quesne G, Coulon S, Berche P, Trieu-Cuot P. (1998). "Identification of streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase". Journal of Clinical Microbiology 38 (1): 415–18. PMC 88737. PMID 10618129. Retrieved 2010-03-16.
- Nawawi RA, Baiano J, Barnes AC. (2008). "Genetic variability amongst Streptococcus iniae isolates from Australia". Journal of Fish Diseases 31 (4): 305–9. doi:10.1111/j.1365-2761.2007.00880.x. PMID 18353022.
- Weinstein MR, Litt M, Kertesz DA, et al. (1997). "Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group". New England Journal of Medicine 337 (9): 589–94. doi:10.1056/NEJM199708283370902. PMID 9271480.
- Lau SK, Woo PC, Tse H, Leung KW, Wong SS, Yuen KY. (2003). "Invasive Streptococcus iniae infections outside North America". Journal of Clinical Microbiology 41 (3): 1004–9. doi:10.1128/JCM.41.3.1004-1009.2003. PMC 150295. PMID 12624022.
- Perera RP, Johnson SK. (1994). "Streptococcus iniae associated with mortality of Tilapia nilotica x T. aurea hybrids". Journal of Aquatic Animal Health 6 (4): 335–40. doi:10.1577/1548-8667(1994)006<0335:SIAWMO>2.3.CO;2.
- Eldar A, Lawhon S, Frelier PF, Assenta L, Simpson BR, Varner PW, Bercovier H. (1997). "Restriction fragment length polymorphisms of 16S rDNA and of whole rRNA genes (ribotyping) of Streptococcus iniae strains from the United States and Israel". FEMS Microbiology Letters 151 (2): 155–62. doi:10.1111/j.1574-6968.1997.tb12564.x. PMID 9228748.
- Facklam R. (2002). "What happened to the streptococci: overview of taxonomic and nomenclature changes". Clinical Microbiology Reviews 15 (4): 613–30. doi:10.1128/CMR.15.4.613-630.2002. PMC 126867. PMID 12364372.
- Scott TM, Rose JB, Jenkins TM, Farah SR, Lukasik J. (2002). "Microbial source tracking: current methodology and future directions". Applied and Environmental Microbiology 68 (12): 5796–803. doi:10.1128/AEM.68.12.5796-5803.2002. PMC 134426. PMID 12450798. Retrieved 2010-03-16.
- Centers for Disease Control and Prevention (CDC) (1996). "Invasive infection with Streptococcus iniae—Ontario, 1995–1996". Morbidity and Mortality Weekly Report 45 (30): 650–53. PMID 8769472.
- Goh SH, Driedger D, Gillett S, et al. (1998). "Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method". Journal of Clinical Microbiology 36 (7): 2164–66. PMC 105023. PMID 9650992.
- Pier GB, Madin SH, Alnakeeb S. (1978). "Isolation and characterization of a 2nd isolate of Streptococcus iniae". International Journal of Systematic Bacteriology 28 (2): 311–14. doi:10.1099/00207713-28-2-311. Retrieved 2010-03-16.
- Bachrach GA, Zlotkin A, Hurvitz A, Evans DL, Eldar A. (2001). "Recovery of Streptococcus iniae from diseased fish previously vaccinated with a Streptococcus vaccine". Applied and Environmental Microbiology 67 (8): 3756–58. doi:10.1128/AEM.67.8.3756-3758.2001. PMC 93086. PMID 11472962. Retrieved 2010-03-16.
- Barnes AC, Young FM, Horne MT, Ellis AE. (2003). "Streptococcus iniae: serological differences, presence of capsule and resistance to immune serum killing". Disease of Aquatic Organisms 53 (3): 241–47. doi:10.3354/dao053241. PMID 12691195.
- Lahav D, Eyngor M, Hurvitz A, Ghittino C, Lublin A, Eldar A. (2004). "Streptococcus iniae type II infections in rainbow trout Oncorhynchus mykiss". Disease of Aquatic Organisms 62 (1–2): 177–80. doi:10.3354/dao062177. PMID 15648844.
- Low DE, Liu E, Fuller J, McGeer A. (1999). "Streptococcus iniae: an emerging pathogen in the aquaculture industry". In W. Michael Scheld, William A. Craig, Donald Armstrong, James M. Hughes. Emerging Infections 3. Washington, DC: ASM Press. pp. 53–65. ISBN 1-55581-168-X. Retrieved on May 6, 2009 through Google Book Search.
- Agnew W, Barnes AC. (2007). "Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination". Veterinary Microbiology 122 (1–2): 1–15. doi:10.1016/j.vetmic.2007.03.002. PMID 17418985.
- Locke JB, Colvin KM, Varki N, Vicknair MR, Nizet V, Buchanan JT. (2007). "Streptococcus iniae beta-hemolysin streptolysin S is a virulence factor in fish infection". Dis. Aquat. Org. 76 (1): 17–26. doi:10.3354/dao076017. PMID 17718161.
- Bromage ES, Thomas A, Owens L. (1999). "Streptococcus iniae, a bacterial infection in barramundi Lates calcarifer". Disease of Aquatic Organisms 36 (3): 177–81. doi:10.3354/dao036177. PMID 10401583.
- Bowser PR, Wooster GA, Getchell RG, Timmons MB. (1998). "Streptococcus iniae infection of tilapia Oreochromis niloticus in a recirculation production facility". Journal of the World Aquaculture Society 29 (3): 335–39. doi:10.1111/j.1749-7345.1998.tb00655.x.
- Ndong D, Chen YY, Lin YH, Vaseeharan B, Chen JC. (2007). "The immune response of tilapia Oreochromis mossambicus and its susceptibility to Streptococcus iniae under stress in low and high temperatures". Fish and Shellfish Immunology 22 (6): 686–94. doi:10.1016/j.fsi.2006.08.015. PMID 17132470.
- Perera RP, Johnson SK, Lewis DH. (1997). "Epizootiological aspects of Streptococcus iniae affecting tilapia in Texas". Aquaculture 152 (1–4): 25–33. doi:10.1016/S0044-8486(96)01450-0.
- Shoemaker CA, Evans JJ, Klesius PH. (2000). "Density and dose: factors affecting mortality of Streptococcus iniae infected tilapia (Oreochromis niloticus)". Aquaculture 188 (3–4): 229–35. doi:10.1016/S0044-8486(00)00346-X.
- Yuasa K, Kitancharoen N, Kataoka Y, Al-Murbaty FA. (1999). "Streptococcus iniae, the causative agent of mass mortality in rabbitfish Siganus canaliculatus in Bahrain". Journal of Aquatic Animal Health 11 (1): 87–93. doi:10.1577/1548-8667(1999)011<0087:SITCAO>2.0.CO;2.
- Colorn A, Diamant A, Eldar A, Kvitt H, Zlotkin A. (2002). "Streptococcus iniae infections in Red Sea cage-cultured and wild fishes". Diseases of Aquatic Organisms 49 (3): 165–70. doi:10.3354/dao049165. PMID 12113301.
- Ferguson HW, St John VS, Roach CJ, Willoughby S, Parker C, Ryan R. (2000). "Caribbean reef fish mortality associated with Streptococcus iniae". The Veterinary Record 147 (23): 662–64. PMID 11131554.
- Austin D, Austin B. (2008). "Characteristics of the diseases". Bacterial Fish Pathogens: Disease of Farmed and Wild Fish. Berlin: Springer. p. 18. ISBN 1-4020-6068-8. Retrieved on May 6, 2009 through Google Book Search.
- "Invasive Infection with Streptococcus iniae—Ontario, 1995–1996". Morbidity and Mortality Weekly Report (MMWR). Centers for Disease Control and Prevention. 1996-08-02. Retrieved 2010-03-06.
- Sun JR, Yan JC, Yeh CY, Lee SY, Lu JJ. (2007). "Invasive infection with Streptococcus iniae in Taiwan". Journal of Medical Microbiology 56 (Pt 9): 1246–49. doi:10.1099/jmm.0.47180-0. PMID 17761491.
- Koh TH, Kurup A, Chen J. (2004). "Streptococcus iniae discitis in Singapore". Emerging Infect. Dis. 10 (9): 1694–96. doi:10.3201/eid1009.040029. PMC 3320292. PMID 15503411.
- Brunt J, Austin B. (2005). "Use of a probiotic to control lactococcosis and streptococcosis in rainbow trout, Oncorhynchus mykiss (Walbaum)". Journal of Fish Diseases 28 (12): 693–701. doi:10.1111/j.1365-2761.2005.00672.x. PMID 16336470.
- Stoffregen DA, Backman SC, Perham RE, Bowser PR, Babish JG. (1996). "Initial disease report of Streptococcus iniae infection in hybrid striped (sunshine) bass and successful therapeutic intervention with the fluoroquinolone antibacterial enrofloxacin". Journal of the World Aquaculture Society 27 (4): 420. doi:10.1111/j.1749-7345.1996.tb00626.x.
- Streptococcosis – Fish expert reviewed and published by WikiVet, accessed 11 October 2011.